Abemaciclib in Patients with End-Stage Renal Disease and Advanced Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Report of 2 Cases
This report of two women with metastatic b reast cancer suggests the potentially safe use of abemaciclib in ESRD, which should be confirmed in more extensive real-life studies.Case Rep Oncol 2022;15:305 –311
Source: Case Reports in Oncology - Category: Cancer & Oncology Source Type: research
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Cardiology | Cardiovascular | Diets | Heart | Hematology | Hormonal Therapy | Hormones | Imodium | Loperamide | Nutrition | Study | Toxicology | Women